* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
Person Signing this Report on Behalf of Reporting Manager:
Name
Title
City, State
Date
Michael J. Burry
Chief Executive Officer
Saratoga, California
2/16/2021
As of 12/31/20, Scion Asset Management held Pfizer, Inc. long call options, which are included in this 13F. As reflected in Information Memo #47935 from The Options Clearing Corporation, upon exercise, holders of certain Pfizer long call options that were in existence prior to a corporate restructuring are entitled to receive 100 shares of Pfizer, Inc., and 12 shares of Viatris, Inc. Some of the Pfizer, Inc. long call options held by Scion are of this type (4,824 out of 8,443 option contracts). However, as of 12/31/20, Scion Asset Management had not exercised these long Pfizer call options, and Scion Asset Management did not otherwise hold long common stock or long call options in Viatris, Inc., and thus no position in Viatris, Inc. is included on this 13F.
Other Included Managers (2):
Num
Name
File Number
1
Scion Asset Partners, LP
028-19326
2
Scion Capital Group, LLC
028-19327
We use cookies and similar technologies to provide certain features, enhance
the user experience and deliver content that is relevant to your interests.
Depending on their purpose, analysis and marketing cookies may be used in
addition to technically necessary cookies. By clicking on "Agree and
continue", you declare your consent to the use of the aforementioned cookies.
Here
you can make detailed settings or revoke your consent (in part if necessary)
with effect for the future. For further information, please refer to our
Privacy Policy
.